The administration of President Donald Trump enacted a series of executive actions beginning January 21, 2025, that significantly reshaped U.S. Involvement in global health initiatives. These actions, ranging from funding restrictions to policy shifts, prompted widespread discussion and debate among public health experts, international organizations, and policymakers. Understanding these changes is crucial for assessing the current landscape of U.S. Global health policy and anticipating future developments. This article provides an overview of key executive actions and their implications, focusing on the verifiable impacts as of today, November 16, 2023.
At the core of many of these changes was a stated goal of prioritizing domestic needs and ensuring greater accountability for U.S. Contributions to international health programs. However, critics argued that some actions undermined long-standing partnerships and jeopardized progress on critical global health challenges, including infectious disease control, maternal and child health, and pandemic preparedness. The term President Trump’s executive actions on global health has become central to discussions about the future of U.S. Foreign policy and its role in addressing global health security.
One of the earliest and most impactful actions was a revised policy regarding funding for international organizations. On January 21, 2025, the President signed an executive order reinstating and expanding the Mexico City Policy, also known as the Protecting Life in Global Health Assistance policy. The State Department details the policy, which requires non-governmental organizations (NGOs) receiving U.S. Global health assistance to certify that they do not provide abortion services or advocacy. This policy, initially implemented by the Reagan administration and subsequently modified by subsequent presidents, was significantly broadened under President Trump to encompass a wider range of health programs, including those focused on HIV/AIDS, and malaria. The impact of this expansion was a reduction in funding for several international organizations providing comprehensive reproductive health services.
Impact on Key Global Health Programs
Several specific global health programs experienced direct consequences from the executive actions. Funding for the World Health Organization (WHO) was a major point of contention. In April 2025, the administration announced its intention to withdraw the United States from the WHO, citing concerns about the organization’s handling of the COVID-19 pandemic and its perceived bias towards China. The Council on Foreign Relations provides a timeline of US involvement with the WHO. This withdrawal, which officially took effect in July 2025, resulted in a significant loss of funding for the WHO and raised concerns about its ability to effectively respond to global health emergencies. While the Biden administration rejoined the WHO in 2021, the initial withdrawal created a period of instability and uncertainty.
The President’s Emergency Plan for AIDS Relief (PEPFAR), a bipartisan initiative credited with saving millions of lives, also faced scrutiny. While funding for PEPFAR was not entirely cut, the administration imposed stricter requirements for program evaluation and accountability. These requirements, while intended to ensure efficient leverage of funds, were criticized by some as creating administrative burdens and hindering the program’s ability to reach vulnerable populations. Concerns were raised that the new requirements could disproportionately affect local organizations and community-based groups that play a critical role in delivering HIV/AIDS services.
Shifting Priorities and the Global Health Security Agenda
The executive actions also reflected a shift in priorities towards bilateral agreements and a focus on “America First” principles. The administration emphasized direct partnerships with specific countries, rather than relying on multilateral organizations. This approach was evident in the administration’s engagement with the Global Health Security Agenda (GHSA), an international effort to strengthen countries’ capacity to prevent, detect, and respond to infectious disease outbreaks. While the administration continued to participate in the GHSA, it prioritized bilateral collaborations and sought to renegotiate existing agreements to better align with U.S. Interests.
the administration implemented changes to U.S. Foreign aid policies, linking aid to countries’ voting records at the United Nations. This policy, which was widely condemned by international observers, raised concerns about the politicization of foreign aid and its potential to undermine U.S. Credibility. Critics argued that linking aid to political considerations could discourage countries from taking independent stances on important global issues.
Implications and Future Outlook
The long-term implications of President Trump’s executive actions on global health are still unfolding. The withdrawal from the WHO, for example, created a void in global health leadership and hampered international efforts to address the COVID-19 pandemic. The restrictions on funding for reproductive health services had a disproportionate impact on women and girls in developing countries. The shift towards bilateral agreements and the politicization of foreign aid strained relationships with key partners and undermined multilateral cooperation.
As of November 2023, the Biden administration has taken steps to reverse some of these policies, including rejoining the WHO and restoring funding to international organizations. However, the legacy of the previous administration continues to shape the landscape of U.S. Global health policy. Ongoing debates center on the appropriate level of U.S. Funding for global health programs, the balance between bilateral and multilateral approaches, and the role of the United States in addressing global health challenges. The next major checkpoint will be the upcoming budget negotiations in early 2024, which will determine the level of funding allocated to various global health initiatives.
The changes enacted during this period underscore the vulnerability of global health initiatives to shifts in political priorities. Continued monitoring and evaluation of these policies are essential to ensure that the United States remains a responsible and effective partner in addressing global health challenges.
Do you have thoughts on these changes to U.S. Global health policy? Share your perspective in the comments below.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical or policy advice.
